A first-in-human phase I study of ATG-031, anti-CD24 antibody, in patients with advanced solid tumors or B-cell non-Hodgkin lymphomas (PERFORM).

Siqing Fu, Sarina A. Piha-Paul, Shivani Singh, Jing Peng, Bridget P. Keenan, Jay M. Mei, Kevin Lynch, Ling Li, Ming Song, Xiaojing (Amily) Zhang. A first-in-human phase I study of ATG-031, anti-CD24 antibody, in patients with advanced solid tumors or B-cell non-Hodgkin lymphomas (PERFORM). Journal of Clinical Oncology. 2024 May 29; 42(16_suppl):tps2691-tps2691.

2024
https://researcherprofiles.org/profile/526945397

Siqing Fu, Sarina A. Piha-Paul, Shivani Singh, Jing Peng, Bridget P. Keenan, Jay M. Mei, Kevin Lynch, Ling Li, Ming Song, Xiaojing (Amily) Zhang